Forte Biosciences, Inc. Soared
Mon, Jul 27, 2026 at 07:38 PM
Forte Biosciences, Inc. (FBRX:NASDAQ) shot up at $76.5, representing a gain of 39.6%. On Mon, Jul 27, 2026, FBRX:NASDAQ hit a New 2-Week High of $76.5. The stock got featured on our News Catalysts scanner on Mon, Jul 27, 2026 at 03:16 PM in the 'ACQUISITION' category. From Mon, Jul 13, 2026, the stock recorded 70.00% Up Days and 72.73% Green Days
About Forte Biosciences, Inc. (FBRX:NASDAQ)
Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases.
Top 10 Gainers:
- T3 Defense Inc Com New (DFNS:NASDAQ), 201.15%
- Baiya International Group Inc. (BIYA:NASDAQ), 116.06%
- Entera Bio Ltd. (ENTX:NASDAQ), 91.22%
- LiveWire Group, Inc. (LVWR:NYSE), 66.44%
- Gossamer Bio, Inc. (GOSS:NASDAQ), 46.62%
- The9 Limited (NCTY:NASDAQ), 41.43%
- Forte Biosciences, Inc. (FBRX:NASDAQ), 39.65%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 37.53%
- NIP Group Inc. (NIPG:NASDAQ), 28.26%
- Skycorp Solar Group Ltd (PN:NASDAQ), 27.07%